ChinaBio Today -- Three life science companies will IPO on Shenzhen’s Growth Enterprise Market (GEM), a new exchange that is about to launch after a long gestation period (see story). All together, ten companies were accepted as the first set of prospective listees. The exchange was established to help smaller technology companies raise money for their enterprises, with the hope that GEM will do for China what the Nasdaq market has done for the US. The three pharmaceutical companies are Lepu Medical Technology (Beijing) Co., Anhui Anke Biotechnology (Group) Co., and Chongqing Lummy Pharmaceutical Co.
